YOUR BUSINESS AUTHORITY
Springfield, MO
The U.S. Food and Drug Administration gave the green light for ovarian cancer drug Lynparza to also be used for treatment of pancreatic cancer.
Developers AstraZeneca and Merck say the drug is an advancement in the pharmaceutical industry.
"Patients with advanced pancreatic cancer historically have faced poor outcomes due to the aggressive nature of the disease and limited treatment advances over the last few decades," said Dave Fredrickson, executive vice president of AstraZeneca's oncology business unit, in a statement.
Read more from CBS News.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Eric Schmitt introduces Modern Skies Act
Caterpillar to acquire John Fabick Tractor Co.
Springfield airport to cut the ribbon on $35M in construction projects
Legacy Bank accused in lawsuit of failing to protect customers in data breach